Quantitative Analysis of SARS-CoV-2 Antibody Levels in Cancer Patients Post Three Doses of Immunization and Prior to Breakthrough COVID-19 Infections

(1) Background: COVID-19 vaccine effectiveness should be carefully evaluated and explicitly defined. To our knowledge, this is the first report to quantitatively evaluate humoral responses post 3 doses of SARS-CoV-2 immunization and prior to breakthrough COVID-19 infection in Canadian cancer patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Macrae, Kathryn, Martinez-Cajas, Jorge, Bessai, Kristin, Abdulhamed, Abulhameed, Gong, Yanping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599995/
https://www.ncbi.nlm.nih.gov/pubmed/36290831
http://dx.doi.org/10.3390/curroncol29100554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599995/
https://www.ncbi.nlm.nih.gov/pubmed/36290831
http://dx.doi.org/10.3390/curroncol29100554

Ejemplares similares